Eczema Free Forever™ Eczema Free Forever™

Combination topical treatment reduces psoriasis severity

The fixed combination of halobetasol and tazarotene topicals significantly reduced the severity of localized disease with a favorable safety profile, shows a study published in the Journal of the American Academy of Dermatology.
Dermatology Times – Dermatology

Immunity persists for at least 3 years after receipt of new shingles vaccine

Immune responses to the latest shingles vaccine (Shingrix) last for at least three years following vaccination. The robust immune responses develop and persist in all age groups, according to a recent study in The Journal of Infectious Diseases.
Dermatology Times – Dermatology

Groundbreaking discovery may lead to new treatments for epithelial cancers

Now, scientists know how one gene mutation leads to skin cancer — as well as other epithelial cancers such as lung, esophagus, mouth and throat. This groundbreaking discovering may lead to the development of new treatments and clinical trials.
Dermatology Times – Dermatology